title: Prostate cancer risk estimation tool use by members of the American Urological Association: a survey based study.
abstract: OBJECTIVE
  Prostate cancer risk estimation tools have been developed to help guide patients and physicians with clinical decision making across all disease states. We assessed use patterns of these tools using an online survey sent to AUA (American Urological Association) members.
  
  
  METHODS
  We distributed a 21-question online survey to 5,674 AUA members to query prostate cancer risk estimation tool use. The survey was divided into 4 categories, including 1) demographics, 2) prebiopsy risk assessment, 3) pretreatment risk assessment and 4) risk estimation tool use.
  
  
  RESULTS
  A total of 565 members (10%) responded to the online survey, of whom 31% reported using a risk estimation tool in the prebiopsy decision setting. Providers who spent more than 20 minutes counseling patients were more likely to use a risk estimation tool (OR 2.2, p <0.01). After the prostate cancer diagnosis 70% of providers used a risk estimation tools to guide treatment recommendations. The total time spent counseling a patient (greater than 30 minutes) and the number of years in practice (fewer than 10) predicted prostate cancer risk tool use (OR 2.4, p <0.01 and 3.4, p <0.01, respectively).
  
  
  CONCLUSIONS
  AUA respondents use risk estimation tools more frequently in the pretreatment setting than in the prebiopsy setting. The time spent counseling patients and the time since graduation from residency predicted the likelihood of using risk estimation tools.
authors.affiliation: Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York.
authors.forename: Brandon J
authors.initials: BJ
authors.lastname: Otto
authors.affiliation: Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York.
authors.forename: E Charles
authors.initials: EC
authors.lastname: Osterberg
authors.affiliation: Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Salgado
authors.affiliation: Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York.
authors.forename: Douglas S
authors.initials: DS
authors.lastname: Scherr
authors.affiliation: Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York; Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria. Electronic address: sfshariat@gmail.com.
authors.forename: Shahrokh F
authors.initials: SF
authors.lastname: Shariat
mesh_terms: D003661:Decision Support Techniques; D006801:Humans; D008297:Male; D049451:Nomograms; D010818:Practice Patterns, Physicians'; D011471:Prostatic Neoplasms / Q000453:epidemiology*; D018570:Risk Assessment; D012955:Societies, Medical; D011795:Surveys and Questionnaires; D014481:United States; D014572:Urology
keywords: nomograms; physician's practice patterns; prostatic neoplasms; questionnaires; risk